NeuroQore, Inc.

MOUNTAIN VIEW, CA · CIK 0002080144 · Medtech · Private

Neuromodulation device for treating major depressive disorder and suicidality

neuroqore.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.5M
1 Form D · Sep 2025
12 months since last filing
Contracts
—
No federal contracts on record
Patents
2
2 granted · 0 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,513,123
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1494WASATCH PHOTONICS, INC.——
1495Circulate Health, Inc.—$11M
1496IRONSIDES MEDICAL INC——
1497NeuroQore, Inc.—$1.5M
1498VIROLOCK TECHNOLOGIES LIMITED LIABILITY COMPANY——
1499Endolumik, Inc.—$2.2M
1500PENDERIA TECHNOLOGIES, INC.—$65K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Adrian ChanDirector · Executive Officer
  • Mehran TalebinejadDirector · Executive Officer

Patents

USPTO · 2 granted of 2

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.